Poseida Therapeutics Inc. (PSTX)
undefined
undefined%
At close: undefined
9.53
0.16%
After-hours Dec 13, 2024, 04:43 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 64.70M 130.36M 31.24K - - - 2.98M 9.77M
Cost of Revenue 156.77M 5.17M 4.55M 2.59M 1.19M 689.00K - -
Gross Profit -92.07M 125.19M -4.52M -2.59M -1.19M -689.00K 2.98M 9.77M
Operating Income -129.50M -59.95M -141.41K -126.55K -85.53M -41.99M -19.67M -5.45M
Interest Income - 6.37M 3.36M 3.51M 1.55M - - -
Pretax Income -123.32M -63.46M -124.97K -129.78K -86.53M -44.61M -20.19M -5.34M
Net Income -123.43M -64.00M 4.40M 2.45M -92.64M -44.40M -19.66M -4.58M
Selling & General & Admin 37.44M 37.54M 35.91K 23.03K 18.46M 9.67M 5.48M 5.13M
Research & Development 156.77M 152.90M 136.73K 103.52K 60.39M 30.88M 19.10M 9.86M
Other Expenses - 2.86M 19.80K 280.00 2.56M -821.00K 37.00K -
Operating Expenses 194.21M 190.44M 172.65K 126.55K 78.85M 40.56M 24.58M 15.00M
Interest Expense 8.67M 6.37M 3.36K 3.51K 3.55M 1.80M 558.00K -
Selling & Marketing Expenses - - - - - - - -220.00K
Cost & Expenses 179.35M 190.44M 172.65K 126.55K 78.85M 40.56M 24.58M 15.22M
Income Tax 107.00K 544.00K -4.53M -2.58M 6.11M -202.00K -527.00K -765.00K
Shares Outstanding (Basic) 90.19M 71.91M 62.18M 36.00M 39.73M 35.93M 39.73M 59.32M
Shares Outstanding (Diluted) 90.19M 71.95M 62.24M 36.00M 39.73M 35.93M 39.73M 59.32M
EPS (Basic) -1.37 -0.89 0.07 0.07 -2.33 -1.24 -0.49 -0.08
EPS (Diluted) -1.37 -0.89 0.07 0.07 -2.33 -1.24 -0.49 -0.08
EBITDA -109.04M -54.77M -117.06M -145.48M -91.68M -45.12M -20.88M -5.12M
Depreciation & Amortization 5.61M 5.17M 4.55M 2.59M 1.19M 689.00K 676.00K 220.00K